Global Retinoblastoma Presentation and Analysis by National Income Level
2020 · JAMA Oncology · 360 citations
https://doi.org/10.1001/jamaoncol.2019.6716
A
Anirban Das
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
344
Papers
2.6K
Citations
24
h-index
62
i10-index
Anirban Das is an academic researcher from University of Engineering & Management. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Genetic factors in colorectal cancer. The author has an h-index of 24, co-authored 293 publications.
ORCID: 0000-0001-7653-9529Papers by this author
worksGenomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
2022 · Nature Medicine · 139 citations
https://doi.org/10.1038/s41591-021-01581-6
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries
2022 · The Lancet Global Health · 138 citations
https://doi.org/10.1016/s2214-109x(22)00250-9
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment
2024 · Nature Communications · 28 citations
https://doi.org/10.1038/s41467-024-49595-1
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies
2024 · Clinical Cancer Research · 22 citations
https://doi.org/10.1158/1078-0432.ccr-24-1611
The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study
2024 · The Lancet Oncology · 14 citations
https://doi.org/10.1016/s1470-2045(24)00640-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat